SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-064838
Filing Date
2022-05-25
Accepted
2022-05-25 20:45:34
Documents
1
Period of Report
2022-05-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2216975-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2216975-1_4seq1.xml 4 3366
  Complete submission text file 0001104659-22-064838.txt   4942
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Reporting) CIK: 0001055919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 22964765

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations